Digital
From static documents to strategic capability: The case for ...
Protocol documentation will become protocol ingestion – an approach that’s automated, consistent, and intelligent.
News
OpenAI introduces GPT-Rosalind, its drug discovery AI
In this week's second AI model launch for life sciences research, OpenAI has introduced GPT-Rosalind, named after UK scientist Rosalind Franklin.
News
Novartis CEO joins board of "responsible" AI firm Anthropic
In another signal of the deepening relationship between the pharma and AI sectors, Novartis CEO Vas Narasimhan has joined the board of Anthropic.
News
Amazon launches its AI drug discovery platform
Amazon has pitched an AI-powered drug discovery platform to the biopharma industry that combines in silico and wet-lab work in a single application.
Digital
Sponsored
Solution Spotlight: InsightBrain – AI-powered precision inte...
InsightBrain gives commercial leaders the signals and direction to deliver stronger launches, defend share, and stay ahead of the competition.
Debates
News
Press Releases
Editor's Picks
Editor's Picks
